ESH MM 2018 | Continuous vs. fixed duration therapy for multiple myeloma?

Jesús San Miguel

Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, discusses continuous and fixed duration therapy.

Share this video